High expression of LONP1 and OSGEPL1 (O-sialoglycoprotein endopeptidase-like protein 1) in multiple myeloma cells were both associated with more aggressive outcomes and a 1.9- and 1.8-fold shorter median survival, respectively (Figure 1B). This evidence concerns the gene LONP1 and plasma cell myeloma.